Safety and Efficacy of Endoscopic Submucosal Dissection in the Management of Gastric Tube Cancers After Esophagectomy: A Systematic Review

Overview

Journal Cureus

Specialty Biomedical Engineering

Date 2023 Jul 18

PMID 37461759

Authors

Rohit Agrawal

James Yang

Saeed Ali

Elie Ghoulam

Hemant Mutneja

Abhishek Bhurwal

Brian Boulay

Edward C Villa

Affiliations

Soon will be listed here.

Abstract

Esophagectomy is the proposed standard of care for resectable primary esophageal cancers and recurrent lesions in the reconstructed gastric tube (GT); however, it carries significant morbidity and mortality. Endoscopic submucosal dissection (ESD) has established its role in the management of primary esophageal cancers with growing evidence of its safety in resecting recurrent primary lesions in GT. Our study aims to evaluate the safety and efficacy of ESD in the management of recurrent, localized primary esophageal cancers in GT. We searched PubMed, CENTRAL, EMBASE, Scopus, and clinical trial registries from inception to March 2023 for articles evaluating the safety and efficacy of ESD in the management of recurrent cancerous lesions in GT. Our primary outcome was the en bloc resection rate. Secondary outcomes were curative resection rate, complete resection rate, intra-procedural complication rate, post-procedure complication rate, and five-year survival rate. Seven studies with a total of 165 patients undergoing 192 ESDs were included in the review. The pooled en bloc resection rate was 92.5% (95% CI: 87.7-95.6), which was reported in all seven studies. Pooled complete resection rate was 78.9% (95% CI: 64.5-88.5) per three studies, pooled curative resection rate was 73.9% (95% CI: 63.5-82.2) per four studies, and pooled intra-procedural complication rate was 10.2% (95% CI: 1.5-46.3), which was reported in four studies. Only three studies reported a five-year survival rate that was 65.5% (95% CI: 56.0-73.9). ESD is safe and efficacious in the management of GT cancer after esophagectomy.

References

Mukasa M, Takedatsu H, Matsuo K, Sumie H, Yoshida H, Hinosaka A . Clinical characteristics and management of gastric tube cancer with endoscopic submucosal dissection. World J Gastroenterol. 2015; 21(3):919-25. PMC: 4299345. DOI: 10.3748/wjg.v21.i3.919. View

Merkow R, Bilimoria K, Keswani R, Chung J, Sherman K, Knab L . Treatment trends, risk of lymph node metastasis, and outcomes for localized esophageal cancer. J Natl Cancer Inst. 2014; 106(7). DOI: 10.1093/jnci/dju133. View

Takahashi H, Arimura Y, Masao H, Okahara S, Tanuma T, Kodaira J . Endoscopic submucosal dissection is superior to conventional endoscopic resection as a curative treatment for early squamous cell carcinoma of the esophagus (with video). Gastrointest Endosc. 2010; 72(2):255-64, 264.e1-2. DOI: 10.1016/j.gie.2010.02.040. View

Sun F, Yuan P, Chen T, Hu J . Efficacy and complication of endoscopic submucosal dissection for superficial esophageal carcinoma: a systematic review and meta-analysis. J Cardiothorac Surg. 2014; 9:78. PMC: 4052291. DOI: 10.1186/1749-8090-9-78. View

Tachibana M, Hirahara N, Kinugasa S, Yoshimura H . Clinicopathologic features of superficial esophageal cancer: results of consecutive 100 patients. Ann Surg Oncol. 2007; 15(1):104-16. DOI: 10.1245/s10434-007-9604-4. View

Izbicki J, Hosch S, Pichlmeier U, Rehders A, Busch C, Niendorf A . Prognostic value of immunohistochemically identifiable tumor cells in lymph nodes of patients with completely resected esophageal cancer. N Engl J Med. 1997; 337(17):1188-94. DOI: 10.1056/NEJM199710233371702. View

Kokawa A, Yamaguchi H, Tachimori Y, Kato H, Watanabe H, Nakanishi Y . Other primary cancers occurring after treatment of superficial oesophageal cancer. Br J Surg. 2001; 88(3):439-43. DOI: 10.1046/j.1365-2168.2001.01696.x. View

Pacifico R, Wang K, Wongkeesong L, Buttar N, Lutzke L . Combined endoscopic mucosal resection and photodynamic therapy versus esophagectomy for management of early adenocarcinoma in Barrett's esophagus. Clin Gastroenterol Hepatol. 2004; 1(4):252-7. View

Park H, Kim D, Gong E, Na H, Ahn J, Lee J . Ten-year experience of esophageal endoscopic submucosal dissection of superficial esophageal neoplasms in a single center. Korean J Intern Med. 2016; 31(6):1064-1072. PMC: 5094928. DOI: 10.3904/kjim.2015.210. View

10.

Nonaka S, Oda I, Sato C, Abe S, Suzuki H, Yoshinaga S . Endoscopic submucosal dissection for gastric tube cancer after esophagectomy. Gastrointest Endosc. 2013; 79(2):260-70. DOI: 10.1016/j.gie.2013.07.059. View

11.

Tawaraya S, Jin M, Matsuhashi T, Suzuki Y, Sawaguchi M, Watanabe N . Advanced feasibility of endoscopic submucosal dissection for the treatment of gastric tube cancer after esophagectomy. Gastrointest Endosc. 2013; 79(3):525-30. DOI: 10.1016/j.gie.2013.10.007. View

12.

Semenkovich T, Hudson J, Subramanian M, Mullady D, Meyers B, Puri V . Trends in Treatment of T1N0 Esophageal Cancer. Ann Surg. 2019; 270(3):434-443. PMC: 6980302. DOI: 10.1097/SLA.0000000000003466. View

13.

Bamba T, Kosugi S, Takeuchi M, Kobayashi M, Kanda T, Matsuki A . Surveillance and treatment for second primary cancer in the gastric tube after radical esophagectomy. Surg Endosc. 2009; 24(6):1310-7. DOI: 10.1007/s00464-009-0766-y. View

14.

Suzuki H, Kitamura M, Saito R, Motoyama S, Ogawa J . Cancer of the gastric tube reconstructed through the posterior mediastinal route after radical surgery for esophageal cancer. Jpn J Thorac Cardiovasc Surg. 2001; 49(7):466-9. DOI: 10.1007/BF02913915. View

15.

Prasad G, Wu T, Wigle D, Buttar N, Wongkeesong L, Dunagan K . Endoscopic and surgical treatment of mucosal (T1a) esophageal adenocarcinoma in Barrett's esophagus. Gastroenterology. 2009; 137(3):815-23. PMC: 3815672. DOI: 10.1053/j.gastro.2009.05.059. View

16.

Okamoto N, Ozawa S, Kitagawa Y, Shimizu Y, Kitajima M . Metachronous gastric carcinoma from a gastric tube after radical surgery for esophageal carcinoma. Ann Thorac Surg. 2004; 77(4):1189-92. DOI: 10.1016/j.athoracsur.2003.09.071. View

17.

Satomi T, Kawano S, Inaba T, Nakagawa M, Mouri H, Yoshioka M . Efficacy and safety of endoscopic submucosal dissection for gastric tube cancer: A multicenter retrospective study. World J Gastroenterol. 2021; 27(11):1043-1054. PMC: 7985736. DOI: 10.3748/wjg.v27.i11.1043. View

18.

Sugiura T, Kato H, Tachimori Y, Igaki H, Yamaguchi H, Nakanishi Y . Second primary carcinoma in the gastric tube constructed as an esophageal substitute after esophagectomy. J Am Coll Surg. 2002; 194(5):578-83. DOI: 10.1016/s1072-7515(02)01135-3. View

19.

Watanabe K, Hikichi T, Nakamura J, Hashimoto M, Takagi T, Suzuki R . Clinical Outcomes and Adverse Events of Endoscopic Submucosal Dissection for Gastric Tube Cancer after Esophagectomy. Gastroenterol Res Pract. 2019; 2019:2836860. PMC: 6421774. DOI: 10.1155/2019/2836860. View

20.

Oyama T, Tomori A, Hotta K, Morita S, Kominato K, Tanaka M . Endoscopic submucosal dissection of early esophageal cancer. Clin Gastroenterol Hepatol. 2005; 3(7 Suppl 1):S67-70. DOI: 10.1016/s1542-3565(05)00291-0. View